Engineered immune cells boost leukemia survival for some

Patients with low disease load had best outcomes in first long-term look

CAR-T cell attacking a leukemia cell

IMMUNE ATTACK  Doctors can engineer a patient’s own immune cells to kill cancer cells. These engineered cells, called CAR-T cells, were effective for some people against relapses of leukemia over the long term. Here, a CAR-T cell (red) attacks a leukemia cell (yellow).

Eye of Science/Science Source

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content